Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Pelican Energy Partners Announces Acquisition of Lancs Industries
-
Schrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities
-
Oshkosh Defense Advances Next-Gen Autonomous Technology for ROGUE-Fires
-
Macy’s, Inc. Provides Fourth Quarter 2024 Update
-
Pelican Energy Partners Announces the Acquisition of Skolnik Industries
-
Porter Secures Sale and Leaseback with Avolon for Four Pratt & Whitney PW1921G Engines
-
CareDx Announces Preliminary Fourth Quarter and Full Year 2024 Results
-
TruFood and Bar Bakers Unite as Tandem Foods, Redefining Customer Partnership in the Better-For-You Snack Industry
-
Barrick Recommends Shareholders Reject TRC Capital’s Below-Market “Mini-Tender” Offer for Common Shares
-
CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering
-
Greenwich LifeSciences Partners with Unicancer Expanding Flamingo-01 into France
-
Bunker Hill Provides Project and Corporate Update
-
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook
-
Aduro Clean Technologies to Ring the Nasdaq Closing Bell on Friday, January 17th, 2025
-
Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue
-
Akero Therapeutics Completes Enrollment of the Double-Blind Portion of the Phase 3 SYNCHRONY Real-World Study Evaluating Efruxifermin (EFX) in Patients with Non-Invasively Diagnosed MASH or MASLD
-
Five Below, Inc. Announces Holiday Sales Results for Quarter-To-Date Through January 4, 2025
-
Verve Therapeutics Announces Pipeline Progress and Anticipated 2025 Milestones
-
Smart Meter Remote Patient Monitoring Achieves Remarkable Growth and Expansion
-
ADMA Biologics Announces Preliminary Full Year 2024 Revenue and Provides Business Update
-
Abercrombie & Fitch Co. Increases Fourth Quarter and Full Year Net Sales Outlook on Better-Than-Expected Holiday Sales
-
Travere Therapeutics Provides Corporate Update and 2025 Outlook
-
Autolus Therapeutics Provides Business Updates and 2025 Overview
-
Destination XL Group, Inc. Reports Holiday Sales Results
-
Fractyl Health Announces Positive Initial Clinical Results Demonstrating Weight Maintenance Following GLP-1 Discontinuation and Revita Procedure in First Patient of the REVEAL-1 Cohort
-
Aquestive Therapeutics Provides Business Update and Outlines Key 2025 Objectives
-
Foghorn Therapeutics Highlights Program Progress and Strategic Objectives for 2025
-
Vera Therapeutics Acquires Global Rights to Novel, Next Generation Dual BAFF/APRIL Inhibitor
-
iBio Announces New Investments from Board Members and Officers
-
Braves Announce Exclusive Gray Media Spring Training Action
-
Beam Therapeutics Announces Progress in Hematology and Genetic Disease Franchises and Outlines Key 2025 Anticipated Catalysts
-
Oatly to Report Fourth Quarter 2024 Financial Results on February 12, 2025
-
Mastercard and FreedomPay Unlock Global Commerce With New Payment Gateway Partnership
-
Amphista Therapeutics appoints Paul Medeiros as Chief Business Officer
-
EDAP Announces Preliminary Record Fourth Quarter Focal One® System Sales and Record U.S. Procedures
-
ClearView Healthcare Partners Makes Strategic Investment in Epistemic AI to Advance Next-Generation Biomedical AI Platform
-
George Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Columbia and Central America
-
Schouw & Co. share buy-back programme, week 2 2025
-
Avacta Appoints Brian Hahn as Chief Financial Officer
-
Virtue Recovery Center Champions Harm Reduction in 2025
-
Alpha Omega awarded GSA OASIS+ IDIQ Contract, Expanding Full and Open Vehicle Portfolio
-
Devon Energy Announces Updates to Executive Leadership Team
-
Taylor Morrison to Host Investor Day on March 6, 2025
-
AECOM announces planned dates for first quarter fiscal 2025 earnings results and conference call
-
Alamos Gold Continues to Define High-Grade Mineralization Across the Island Gold Deposit; Ongoing Success Expected to Drive Additional Growth in Mineral Reserves and Resources
-
Vision Marine Technologies Announces $5.8 Million Private Placement
-
New ASCCP Guidelines Include More Precise Method of Cervical Cancer Screening
-
Wallbox’s Quasar 2 Receives U.S. Product Certification from UL Solutions
-
AVPro Global Appoints Loel Wheeler as VP of Sales for Murideo
-
Pharvaris Outlines 2025 Strategic Priorities
